Key market opportunities include leveraging molecular switches for targeted drug delivery systems and therapies in oncology, autoimmune, inflammatory, and neurological disorders. Innovations in ...
In a study published in the Journal of Extracellular Vesicles, scientists from the UF Health Cancer Institute have found a way to make treatment for a notoriously aggressive breast cancer more ...
Targeted drug delivery has long been a cornerstone goal of modern medicine—sending therapies exactly where they’re needed while sparing healthy tissues. Yet creating treatments that can decide when ...
Near-term applications include combinations with kinase inhibitors (KIs)that achieve enhanced concentration at target sites and synergistic delivery of multiple KIs to the same location HOUSTON, TX / ...
Recent advances in nanomedicine have brought significant improvements to drug delivery systems, yet persistent hurdles remain, including poor targeting, ...
The vector consists of a polyethylene glycolylated liposomal outer coat (providing immune evasion and prolonged circulation), a spindle-shaped nanomotor (resembling a flagellum, facilitating targeted ...
The field of cancer immunotherapy has achieved remarkable progress, introducing strategies such as immune checkpoint inhibitors and adoptive cell therapies ...
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform Esco Aster, a vertically integrated ...
ShineOn's proprietary product, SOB100, a HLA-G targeted exosome drug delivery carrier, has passed the U.S. FDA IND review and ongoing Phase I study, making it as a first-in-class–potential HLA-G ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback